Ikena Oncology, Inc. financial data

Symbol
IKNA on Nasdaq
Location
50 Northern Ave., Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 846 % -43.9%
Debt-to-equity -16.6 % -34.7%
Return On Equity 60.3 % +65.7%
Return On Assets -51.6 % -68.9%
Operating Margin -823 % -81.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.2M shares -76.8%
Common Stock, Shares, Outstanding 48.3M shares 0%
Entity Public Float 51.3M USD -71.3%
Common Stock, Value, Issued 48K USD 0%
Weighted Average Number of Shares Outstanding, Basic 8.53M shares +509%
Weighted Average Number of Shares Outstanding, Diluted 48.3M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.5M USD +195%
Research and Development Expense 30.8M USD -18.1%
General and Administrative Expense 31.8M USD +49.7%
Operating Income (Loss) -69M USD -19%
Nonoperating Income (Expense) 16.7M USD +211%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -52.3M USD +0.6%
Income Tax Expense (Benefit) 32K USD
Net Income (Loss) Attributable to Parent -55.9M USD -9.12%
Earnings Per Share, Basic 0 USD/shares +72.7%
Earnings Per Share, Diluted 0 USD/shares +72.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 103M USD +128%
Marketable Securities, Current 39.4M USD -57.5%
Cash, Cash Equivalents, and Short-term Investments 176M USD +11.9%
Other Assets, Current 1.15M USD +19.3%
Assets, Current 148M USD +4.24%
Property, Plant and Equipment, Net 419K USD -45.7%
Operating Lease, Right-of-Use Asset 884K USD -78.8%
Other Assets, Noncurrent 4.95M USD
Assets 161M USD +7.98%
Accounts Payable, Current 2.08M USD +35.1%
Employee-related Liabilities, Current 1.99M USD +14%
Contract with Customer, Liability, Current 659K USD -94.6%
Liabilities, Current 11.1M USD +20.6%
Operating Lease, Liability, Noncurrent 1.28M USD -71.3%
Other Liabilities, Noncurrent 1.11M USD +6.03%
Liabilities 21M USD +42.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 94K USD -60.8%
Retained Earnings (Accumulated Deficit) -223M USD +30.8%
Stockholders' Equity Attributable to Parent 140M USD
Liabilities and Equity 161M USD +7.98%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.6M USD +42.3%
Net Cash Provided by (Used in) Investing Activities 7.93M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 48.3M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 103M USD +1082%
Deferred Tax Assets, Valuation Allowance 112M USD +10.4%
Deferred Tax Assets, Gross 113M USD +9.21%
Operating Lease, Liability 7.52M USD -30%
Depreciation 87K USD -60.3%
Payments to Acquire Property, Plant, and Equipment 152K USD +361%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -51.8M USD +1.46%
Lessee, Operating Lease, Liability, to be Paid 8.1M USD -32.6%
Property, Plant and Equipment, Gross 2.04M USD -59.8%
Operating Lease, Liability, Current 2.16M USD -44.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.17M USD -24.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.21M USD +7.34%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 582K USD -54.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 720K USD -77.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.01M USD +6.22%
Lessee, Operating Lease, Liability, to be Paid, Year Four 719K USD -12%
Additional Paid in Capital 363M USD -20.5%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 14.9M USD +1065%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%